ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $30,010,000 | -27.5% | 8,002,700 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $41,374,000 | +21.4% | 8,002,700 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $34,092,000 | -19.8% | 8,002,700 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $42,494,000 | -1.5% | 8,002,700 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $43,135,000 | -32.5% | 8,002,700 | 0.0% | 0.01% | -42.9% |
| Q3 2020 | $63,862,000 | -20.3% | 8,002,700 | 0.0% | 0.01% | -26.3% |
| Q2 2020 | $80,107,000 | +268.0% | 8,002,700 | 0.0% | 0.02% | +216.7% |
| Q1 2020 | $21,767,000 | +167.0% | 8,002,700 | +17.8% | 0.01% | +200.0% |
| Q4 2019 | $8,151,000 | -20.5% | 6,792,700 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,257,000 | -62.4% | 6,792,700 | 0.0% | 0.00% | -66.7% |
| Q2 2019 | $27,307,000 | -6.5% | 6,792,700 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $29,209,000 | -25.2% | 6,792,700 | 0.0% | 0.01% | -36.4% |
| Q4 2018 | $39,058,000 | -57.6% | 6,792,700 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $92,109,000 | +8.0% | 6,792,700 | -5.5% | 0.02% | +22.2% |
| Q2 2018 | $85,306,000 | +11.8% | 7,186,700 | +5.8% | 0.02% | +5.9% |
| Q1 2018 | $76,282,000 | +68.1% | 6,792,700 | 0.0% | 0.02% | +70.0% |
| Q4 2017 | $45,375,000 | -18.4% | 6,792,700 | 0.0% | 0.01% | -23.1% |
| Q3 2017 | $55,632,000 | +82.4% | 6,792,700 | 0.0% | 0.01% | +85.7% |
| Q2 2017 | $30,499,000 | -18.5% | 6,792,700 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $37,428,000 | +106.3% | 6,792,700 | +51.6% | 0.01% | +80.0% |
| Q4 2016 | $18,146,000 | -44.1% | 4,480,486 | -2.6% | 0.01% | -37.5% |
| Q3 2016 | $32,437,000 | -13.5% | 4,601,000 | 0.0% | 0.01% | -20.0% |
| Q2 2016 | $37,498,000 | +0.2% | 4,601,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $37,406,000 | -32.6% | 4,601,000 | 0.0% | 0.01% | -37.5% |
| Q4 2015 | $55,488,000 | +170.5% | 4,601,000 | +168.4% | 0.02% | +166.7% |
| Q3 2015 | $20,516,000 | +2.3% | 1,713,918 | +56.7% | 0.01% | +20.0% |
| Q2 2015 | $20,048,000 | – | 1,093,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,054,864 | $8,597,000 | 5.88% |
| NEA Management Company, LLC | 9,880,999 | $80,530,000 | 4.18% |
| Abingworth LLP | 250,000 | $2,033,000 | 2.13% |
| New Leaf Venture Partners, L.L.C. | 127,041 | $1,035,000 | 0.89% |
| Iguana Healthcare Management, LLC | 200,000 | $1,630,000 | 0.66% |
| Rock Springs Capital Management LP | 765,001 | $6,235,000 | 0.46% |
| QVT Financial LP | 783,645 | $6,387,000 | 0.44% |
| Opaleye Management Inc. | 40,000 | $326,000 | 0.22% |
| Rathbones Group PLC | 450,525 | $3,672,000 | 0.20% |
| Virtus ETF Advisers LLC | 26,974 | $220,000 | 0.16% |